Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T02:12:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T02:14:05.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 is added to the history and the previous revision v3.6.6 is removed, updating the study record’s version history.
    Difference
    0.1%
    Check dated 2026-09-20T01:17:55.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 was added to the study record history, while the previous revision v3.6.5 is removed from the list; this reflects an update to the page's versioning metadata in the history.
    Difference
    0.1%
    Check dated 2026-08-29T19:08:58.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The study page's revision history shows a new Revision: v3.6.5, replacing v3.6.4. This reflects a software release update to the ClinicalTrials.gov page rather than changes to study content.
    Difference
    0.1%
    Check dated 2026-08-08T19:12:37.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 appears in the study record history, and Revision: v3.6.3 is removed. This update reflects an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-07-25T10:51:30.000Z thumbnail image

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.